Association of PFS with levels of pretreatment lactate dehydrogenase in patients with EML4-ALK rearrangement non-small cell lung cancer treated with ALK tyrosine kinase inhibitor.

Hongge Liang,Di Ma,Yan Xu,Jing Zhao,Minjiang Chen,Xiaoyan Liu,Wei Zhong,Mengzhao Wang,Li Junling

Association of PFS with levels of pretreatment lactate dehydrogenase in patients with EML4-ALK rearrangement non-small cell lung cancer treated with ALK tyrosine kinase inhibitor.

2019

Hongge Liang
Di Ma
Yan Xu
Jing Zhao
Minjiang Chen
Xiaoyan Liu
Wei Zhong
Mengzhao Wang
Li Junling

e20513Background: We performed a retrospective analysis to investigate the association between the lactate dehydrogenase (LDH) levels and progression-free survival (PFS) in patients with echinoderm...

Keywords:

Cancer research
ALK Rearrangement
Tyrosine-kinase inhibitor
Lactate dehydrogenase
Lung cancer
Cell
Pathology
Medicine
in patient
retrospective analysis
non small cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations